Phenytoin, known by brand names like Dilantin®, is a well-established anticonvulsant medication primarily used to manage epilepsy. However, its mechanism of action, which involves stabilizing nerve membranes, also makes it effective for various types of nerve-related pain, including trigeminal neuralgia (TN). Its use in TN has a long history, though its role has shifted over time due to the introduction of other medications with better tolerability. Today, phenytoin is most commonly utilized in specific circumstances, such as in acute emergency situations or for patients who have not found success with standard treatments.
The Mechanism of Action: Stabilizing Overactive Nerves
The hallmark of trigeminal neuralgia is the sudden, severe, and debilitating facial pain caused by abnormal hyperexcitability of nerve fibers. Phenytoin works by targeting these overactive nerves. Its core mechanism involves the blockade of voltage-gated sodium channels. These channels are crucial for transmitting electrical signals along nerve fibers. By blocking them, phenytoin helps to:
- Reduce the rapid, high-frequency firing of nerve cells responsible for intense pain attacks.
- Stabilize the neuronal membrane, making it less excitable.
This action is similar to that of carbamazepine, the current first-line treatment, which also acts as a sodium channel blocker. This shared mechanism is why anticonvulsants are a cornerstone of TN pharmacotherapy, as they directly address the underlying neurological dysfunction causing the pain.
Current Use of Phenytoin in Trigeminal Neuralgia
While once used more broadly, modern treatment strategies reserve phenytoin for specific roles in TN management. These include:
Acute Exacerbations and Crises
In cases of a severe, acute TN crisis where oral medications are insufficient or the patient is unable to swallow, intravenous (IV) phenytoin or its prodrug fosphenytoin is often used as a rescue treatment. A retrospective study demonstrated significant or complete pain relief in a majority of patients treated with IV phenytoin for acute TN exacerbations. This provides rapid, temporary relief, creating a window of opportunity to adjust long-term oral medication or prepare for other interventions.
Adjunctive or Alternative Therapy
For long-term management, oral phenytoin is not the first-line drug of choice due to a less favorable side effect profile and potentially lower efficacy compared to carbamazepine. However, it may be used in the following scenarios:
- Refractory Cases: When a patient's pain is not adequately controlled by first-line medications, phenytoin can be added to their existing regimen.
- Intolerance to First-line Agents: For individuals who experience intolerable side effects from first-line drugs like carbamazepine, phenytoin can be a viable alternative.
It is crucial that any use of phenytoin be carefully managed and monitored by a healthcare provider, particularly for patients with complex medical histories.
Comparison of Phenytoin and Carbamazepine
Carbamazepine is the most widely studied and recommended first-line oral medication for trigeminal neuralgia. Below is a comparison to clarify why phenytoin is typically considered a secondary option for chronic oral management.
Feature | Phenytoin | Carbamazepine |
---|---|---|
Efficacy | Effective, but generally considered less potent for chronic management than carbamazepine. Effective for acute crises via IV infusion. | Considered the most effective oral treatment for initial pain control. |
Side Effects | Narrow therapeutic index and significant side effects, especially with long-term use (e.g., gum overgrowth, neurological issues, skin rashes). | Common side effects include dizziness and fatigue, but can cause more serious issues, though generally considered better tolerated than phenytoin. |
Drug Interactions | Prone to numerous drug interactions. | Also has significant drug interaction potential. |
Monitoring | Requires regular monitoring of blood levels and potential side effects. | Requires regular monitoring of blood levels, liver function, and blood cell counts. |
Role in Therapy | Second-line or adjunctive oral therapy; primary role is often IV rescue for acute crises. | First-line oral therapy for initial pain management. |
Potential Side Effects and Monitoring
Phenytoin is effective but its use requires careful consideration of its side effect profile, which can be more challenging than with some other anticonvulsants. Long-term oral use is particularly associated with certain adverse effects:
- Neurological: Dizziness, incoordination (ataxia), slurred speech, confusion, and involuntary eye movements (nystagmus) can occur, especially at higher doses.
- Gastrointestinal: Nausea and vomiting are possible side effects.
- Oral Health: Long-term use can cause an overgrowth of gum tissue, making good oral hygiene essential.
- Cosmetic: Unwanted hair growth (hirsutism) and coarsening of facial features are potential long-term side effects.
- Serious Reactions: Rare but serious reactions, including severe skin rashes like Stevens-Johnson syndrome, can occur.
Due to its narrow therapeutic index, blood levels of phenytoin need to be regularly monitored to ensure they are within the effective range and to avoid toxicity. A healthcare provider will weigh these risks against the potential benefits, especially in older patients who may be more susceptible to adverse effects.
Alternative and Adjunctive Treatments
For patients with trigeminal neuralgia, especially those who cannot tolerate or do not respond to phenytoin and carbamazepine, other medications are available. These are typically considered second-line oral options or are used in combination with first-line agents.
Other Oral Anticonvulsants
- Oxcarbazepine: Similar to carbamazepine but with fewer side effects and drug interactions. It is often a preferred alternative.
- Lamotrigine: Can be effective as an add-on therapy.
- Gabapentin and Pregabalin: Often used for neuropathic pain and can be effective, particularly in patients with TN secondary to multiple sclerosis.
Other Medications
- Baclofen: A muscle relaxant that can be used alone or combined with anticonvulsants.
- Botulinum Toxin Type A: Injections of botulinum toxin have shown efficacy in treating TN.
- Intravenous Lacosamide: An alternative to IV phenytoin for acute rescue treatment, potentially with a better tolerability profile.
Surgical Options
For patients with medication-refractory TN, several surgical procedures are available, including microvascular decompression (MVD), radiosurgery, and rhizotomy. A multidisciplinary team approach is often best for managing complex cases, considering both pharmacologic and surgical interventions.
Conclusion
In summary, is phenytoin used for trigeminal neuralgia? Yes, but its role today is highly specific, primarily as an effective intravenous rescue medication for acute pain crises and as a second-line or adjunctive oral treatment for patients who do not respond to or tolerate first-line therapies. While its efficacy in calming overactive nerves is well-documented, its side effect profile makes it a less favorable long-term oral option compared to carbamazepine and newer agents. Clinicians must weigh the benefits against the risks, ensuring patients are closely monitored for potential adverse effects, especially with chronic use. With a variety of treatment options available, the management of TN is best approached individually, tailoring the therapeutic strategy to the patient's specific needs and response to therapy. For more detailed information on treatments, consult an authoritative source like the National Health Service (NHS) in the UK.
NHS information on phenytoin for trigeminal neuralgia
References
Phenytoin relieves acute exacerbations of trigeminal neuralgia. (2024). Sage Journals. Retrieved from https://journals.sagepub.com/doi/10.1177/25158163241268880 Phenytoin: medicine for epilepsy and trigeminal neuralgia - NHS. (n.d.). nhs.uk. Retrieved from https://www.nhs.uk/medicines/phenytoin/ Trigeminal Neuralgia Crisis - Intravenous Phenytoin as Acute... (2020). pubmed.ncbi.nlm.nih.gov. Retrieved from https://pubmed.ncbi.nlm.nih.gov/32981076/ Trigeminal Neuralgia Treatment & Management. (2025). emedicine.medscape.com. Retrieved from https://emedicine.medscape.com/article/1145144-treatment About phenytoin - NHS. (n.d.). nhs.uk. Retrieved from https://www.nhs.uk/medicines/phenytoin/about-phenytoin/ Trigeminal Neuralgia Medication - Medscape Reference. (2025). emedicine.medscape.com. Retrieved from https://emedicine.medscape.com/article/1145144-medication 9 Common and Rare Phenytoin Side Effects - GoodRx. (2023). goodrx.com. Retrieved from https://www.goodrx.com/phenytoin/common-side-effects Phenytoin: MedlinePlus Drug Information. (2023). medlineplus.gov. Retrieved from https://medlineplus.gov/druginfo/meds/a682022.html Trigeminal neuralgia: a practical guide. (n.d.). pn.bmj.com. Retrieved from https://pn.bmj.com/content/21/5/392 Fosphenytoin: An Intravenous Option for the Management of Acute ... (2001). sciencedirect.com. Retrieved from https://www.sciencedirect.com/science/article/pii/S088539240100269X